Pretreatment of Acute Coronary Syndrome With Dual Antiplatelet Agents

Recruiting now

Conditions studied: Major Bleeding, Major Adverse Cardiovascular and Cerebrovascular Events (MACCE)

In brief

This is a chart review of data on use of antiplatelet (AP) medications for acute coronary syndrome in the ER. Guidelines recommend giving aspirin in the ER and a second AP agent in the cath lab. What is the outcome when the 2 agents are given n the ER?

Key facts

Study ID

NCT07039149

Run by

Jordan Collaborating Cardiology Group

People needed

200

Starts

2025-08-01

Expected to finish

2026-11-01

Last updated by the study team

2025-11-28

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Adult patients
• Presenting with acute coronary syndrome (ST segment elevation myocardial infarction, non ST segment elevation myocardial infarction, and unstable angina).
• Antiplatelet medication (s) prescribed during index admission to hospital.
• Willingness of the patient to be called for follow up up to 1 year after index hospitalization.

You may not qualify if…

• Non cardiac chest pain.
• No administration of antiplatelet agents during hospitalization.
• Refusal of contact for follow up.

Where it is running

• Jordan University Hospital — Amman, Jordan (enrolling)
• Istishari Hospital — Amman, Jordan

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.